Out with the Old: How CalEthos Is Giving Brands a Voice and Consumers an Educated Choice
Robin Lefferts
March 3rd, 2020
App, Exclusive, News, Top Story
For a revolutionary movement, the cannabis industry still seems to have a lot of “same old, same old.” Cannabis brands increasingly must face many of the challenges that other CPG businesses have long confronted – including distribution, retail visibility, and consumer education – while complying with regulations that leave one hand tied behind their backs.
One common CPG hassle now emerging in the cannabis space is the rise of slotting fees. Slotting fees, paid by brands to guarantee shelf space and placement for their products in stores, have long been employed by supermarkets and other large retailers.
According to a recent article in Marijuana Business Daily, cannabis dispensary slotting fees can range from $500 to $15,000 a month per store, depending on the volume of sales in the store and the size of the space reserved. It’s a significant expense. But as product makers struggle to differentiate their brands and create loyal customers in crowded, confusing dispensary environments, they’re handing over big sums to gain small advantages.
A new dispensary concept in Southern California isn’t satisfied with this status quo. In a market flooded by sameness, CalEthos (OTC-Pink: BUUZ) is offering brands and consumers a new and better experience.
Click Here to Receive a CalEthos Investor Presentation & Company Updates
The company’s SHOWCASE stores will offer brands their own store-within-the-store boutique, shared kiosk, or area in a product section featuring all of a brand’s product line and staffed by a dedicated and knowledgeable salesperson. Rather than just guaranteeing some amount of shelf space, this model gives participating brands a true platform to showcase their products, engage directly with consumers, and develop loyal followings.
Rendering of a SHOWCASE store-within-the-store boutique
Stores-Within-A-Store vs. Shelf Space
In developing the model for the SHOWCASE stores, CalEthos did a bit of talking and a lot of listening. They investigated in depth the issues facing product manufacturers. Because of regulatory and financial constraints, most brands are unable to create their own retail outlets. They are at the mercy of licensed dispensaries, many of which lack adequate space to properly display the wide variety of products they carry. What’s more, they are often understaffed, or not staffed to a level that allows for in-depth consultation and education about specific brands or products.
Click Here to Receive a CalEthos Investor Presentation & Company Updates
With cannabis so new to the general consumer population, more interaction would be ideal to help a customer decide how to choose from the myriad of product choices, and even product categories. Vape vs. smoking? Edibles, oils, tinctures? What product might help with relaxation, or sleep, or provide pain relief? CalEthos learned that neither brands nor consumers were being well-served by the current setup in many dispensaries. This is especially true for those CalEthos calls the “canna-curious” — potential customers who lack extensive experience with cannabis and may be intimidated by traditional marijuana culture.
In response, CalEthos designed a concept to elevate cannabis retail to a new level, starting in the largest and most trend-setting legal cannabis market in the world, Southern California. CalEthos’s SHOWCASE stores will feature a large-format, department store-style footprint. The space will be anchored by in-store boutiques dedicated to major brands and staffed by brand-specific representatives. Each boutique measures 10’ x 16’ and includes 90’ of shelf space. Imagine the Clinique counter at a Neiman Marcus, where consumers experience the full range of products and get advice from a dedicated, on-brand salesperson. Gone is the cramped competition for a little shelf space, replaced by the best possible display and direct customer engagement a cannabis brand can get in the Southern California market today.
If a brand isn’t ready for its own boutique, it can subscribe to a smaller display area of 18’ to 21’ of shelf space in one of SHOWCASE’s specialty sections defined by product type – like flower, vape, concentrates, CBD, and more. Each store will also feature Chill Zone section dedicated to edible and beverage products, with refrigerated floor and wall coolers that are used for both brand display and inventory storage.
Beyond this innovative retail experience, SHOWCASE stores are also designed to engage and educate consumers in a way no corner dispensary or illicit seller can. With a world-class event center integrated into each location, brand partners can participate in daily educational and promotional events, with access to full production and streaming capabilities. The stores will also offer an in-store pharmacy with certified cannabis pharmacists available for consultation and advice on medicinal remedies and medical cannabis treatments.
It’s a ground-breaking model in an market dominated by copycats – a model created to deliver an expanded customer base and substantial foot traffic for brand partners, an elevated experience for consumers, and significant recurring non-retail revenue for CalEthos.
In short, the SHOWCASE concept is designed to facilitate successful brand building and give consumers the space to explore, learn, and make their own unique, educated cannabis choices. No “same old, same old” here.
Rendering of a SHOWCASE Event Center
Interested in Investing?
CalEthos is currently financing its initial SHOWCASE location planned for Santa Ana, California. The building and licenses are secured, and the retrofit of the facility is poised to begin. If you are interested in finding out more about this investment opportunity, please click on any of the links below to get in touch with the CalEthos Team.
Click Here to Receive a CalEthos Investor Presentation & Company Updates
Take the 2-minute Virtual Tour and Step Inside a CalEthos SHOWCASE Superstore & Event Center
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Robin Lefferts
Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
